Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2191-2200 of 2400 for

Edit search filters
  1. A Study to Assess Dynamic Changes in Plasma Proteome to Identify Early Detection and Treatment Response Biomarkers for HGSOC

    Rochester, MN

  2. A Study to See if the Depth of Tumor Invasion of Esophageal Carcinoma Predicts Lymph Node Involvement and Cancer Free Survival

    Rochester, MN

  3. A Study to Explore Cancer Patient Experiences and Their Decisions About Sharing Genetic Cancer Screening Information with Family Members

    Rochester, MN

  4. Care Processes and Person Centered Care of Patients with Neuroendocrine Tumors

    Rochester, MN

  5. A Study to Evaluate Effectiveness and Quality of Life Outcomes of Daratumumab in Relapsed/Refractory Multiple Myeloma Patients

    Rochester, MN

  6. Endometrial Cancer/Endometrial Atypical Hyperplasia with an AI-based Classifier in Transvaginal Ultrasound in Patients with Post-Menopausal Bleeding

    Scottsdale/Phoenix, AZ, Rochester, MN, Jacksonville, FL

  7. Impact Of Restricted Medication Access On Care Of Multiple Myeloma Patients

    Rochester, MN

  8. Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence

    Rochester, MN

  9. A Comprehensive Evaluation Of Immunity In Lymphoma Patients

    Rochester, MN

  10. A Study to Analyze Symptoms and Quality of Life Issues in Women Living with Metastatic Breast Cancer

    Jacksonville, FL

.

Mayo Clinic Footer